Cargando…

ARHGEF38 as a novel biomarker to predict aggressive prostate cancer

Prostate cancer (PCa) metastasis is considered the leading cause of cancer death in males. Therapeutic strategies and diagnosis for stage-specific PCa have not been well understood. Rho guanine nucleotide exchange factor 38 (ARHGEF38) is related to tumor cell polarization and is frequently expressed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Kun, Wang, Aixiang, Ran, Longke, Zhang, Wanfeng, Jing, Song, Wang, Yujing, Zhang, Xianqin, Liu, Geli, Sen, Wang, Song, Fangzhou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Chongqing Medical University 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083745/ https://www.ncbi.nlm.nih.gov/pubmed/32215291 http://dx.doi.org/10.1016/j.gendis.2019.03.004

Ejemplares similares

FOXS1 is regulated by GLI1 and miR-125a-5p and promotes cell proliferation and EMT in gastric cancer
por: Wang, Sen, et al.
Publicado: (2019)

SLCO4C1 promoter methylation is a potential biomarker for prognosis associated with biochemical recurrence-free survival after radical prostatectomy
por: Li, Xin, et al.
Publicado: (2019)

Multi-omics analysis reveals epithelial-mesenchymal transition-related gene FOXM1 as a novel prognostic biomarker in clear cell renal carcinoma
por: Song, Jing, et al.
Publicado: (2019)

LINC01272 Promotes Migration and Invasion of Gastric Cancer Cells via EMT
por: Leng, Xue, et al.
Publicado: (2020)

Identification of ARHGEF38, NETO2, GOLM1, and SAPCD2 Associated With Prostate Cancer Progression by Bioinformatic Analysis and Experimental Validation
por: Sun, Zhuolun, et al.
Publicado: (2021)

Pan-Cancer Analysis Reveals the Signature of TMC Family of Genes as a Promising Biomarker for Prognosis and Immunotherapeutic Response
por: Song, Jing, et al.
Publicado: (2021)

Identifying CpG methylation signature as a promising biomarker for recurrence and immunotherapy in non–small-cell lung carcinoma
por: Luo, Ruihan, et al.
Publicado: (2020)

The clonal expression genes associated with poor prognosis of liver cancer
por: Zhang, Wanfeng, et al.
Publicado: (2022)

Identification of immune-related cells and genes in the breast invasive carcinoma microenvironment
por: Chen, Xingfeng, et al.
Publicado: (2022)

SMAGP a novel biomarker of cervical cancer development and progression
por: Jia, Yongqin, et al.
Publicado: (2018)

Comparison of Robotic Surgery with Laparoscopy and Laparotomy for Treatment of Endometrial Cancer: A Meta-Analysis
por: Ran, Longke, et al.
Publicado: (2014)

Combined ARHGEF6 and Tumor Mutational Burden may serve as a potential biomarker for immunotherapy of lung adenocarcinoma
por: Tong, Li, et al.
Publicado: (2023)

Integrative analysis of the gastric cancer long non-coding RNA-associated competing endogenous RNA network
por: Jiang, Yuyou, et al.
Publicado: (2021)

Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancer
por: Sahoo, Debashis, et al.
Publicado: (2018)

Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
por: Chen, Xuanrong, et al.
Publicado: (2022)

ARHGEF3 Associated with Invasion, Metastasis, and Proliferation in Human Osteosarcoma
por: Gong, Jie, et al.
Publicado: (2021)

Correction: Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
por: Chen, Xuanrong, et al.
Publicado: (2023)

ARHGEF3 regulates the stability of ACLY to promote the proliferation of lung cancer
por: Zhou, Feifei, et al.
Publicado: (2022)

Transgenerational Obesity and Alteration of ARHGEF11 in the Rat Liver Induced by Intrauterine Hyperglycemia
por: Zhang, Wanyi, et al.
Publicado: (2019)

The exon 38-containing ARHGEF11 splice isoform is differentially expressed and is required for migration and growth in invasive breast cancer cells
por: Itoh, Masahiko, et al.
Publicado: (2017)

ARHGEF26 enhances Salmonella invasion and inflammation in cells and mice
por: Bourgeois, Jeffrey S., et al.
Publicado: (2021)

Loss of ARHGEF6 Causes Hair Cell Stereocilia Deficits and Hearing Loss in Mice
por: Zhu, Chengwen, et al.
Publicado: (2018)

Activation of neural lineage networks and ARHGEF2 in enzalutamide-resistant and neuroendocrine prostate cancer and association with patient outcomes
por: Ning, Shu, et al.
Publicado: (2022)

Impairment of social behaviors in Arhgef10 knockout mice
por: Lu, Dai-Hua, et al.
Publicado: (2018)

ARHGEF7 promotes metastasis of colorectal adenocarcinoma by regulating the motility of cancer cells
por: Lei, Xiong, et al.
Publicado: (2018)

FYN is required for ARHGEF16 to promote proliferation and migration in colon cancer cells
por: Yu, Bei, et al.
Publicado: (2020)

Biomarkers of Aggressive Prostate Cancer at Diagnosis
por: Boehm, Brock E., et al.
Publicado: (2023)

SNP in human ARHGEF3 promoter is associated with DNase hypersensitivity, transcript level and platelet function, and Arhgef3 KO mice have increased mean platelet volume
por: Zou, Siying, et al.
Publicado: (2017)

ARHGEF17 sets the timer for retention of Mps1 at kinetochores
por: Marquardt, Joseph R., et al.
Publicado: (2016)

ARHGEF9 disease: Phenotype clarification and genotype-phenotype correlation
por: Alber, Michael, et al.
Publicado: (2017)

Identification of genetic variations associated with drug resistance in non-small cell lung cancer patients undergoing systemic treatment
por: Luo, Ruihan, et al.
Publicado: (2021)

Novel serum proteomic biomarkers for early diagnosis and aggressive grade identification of prostate cancer
por: Wang, Ce, et al.
Publicado: (2022)

Clinical implication and potential function of ARHGEF6 in acute myeloid leukemia: An in vitro study
por: Li, Kang, et al.
Publicado: (2023)

ARHGEF4-mediates the actin cytoskeleton reorganization of hepatic stellate cells in 3-dimensional collagen matrices
por: Zhang, Xiaowei, et al.
Publicado: (2019)

A panel of selected serum protein biomarkers for the detection of aggressive prostate cancer
por: Song, Jin, et al.
Publicado: (2021)

Blood-Based Biomarkers of Aggressive Prostate Cancer
por: Liong, Men Long, et al.
Publicado: (2012)

Evaluation of protein biomarkers of prostate cancer aggressiveness
por: Rizzardi, Anthony E, et al.
Publicado: (2014)

ARHGEF11, a regulator of junction-associated actomyosin in epithelial cells
por: Itoh, Masahiko
Publicado: (2013)

Arhgef1 Plays a Vital Role in Platelet Function and Thrombogenesis
por: Qasim, Hanan, et al.
Publicado: (2019)

Role of ARHGEF3 as a GEF and mTORC2 Regulator
por: Khaliq, Sana Abdul, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o1gaq80t82s24h6bcjc5kcq856